BUY Infosys — Motilal Oswal
byMotilal OswalHorizon: NA (inferred 1 year)23 Jul 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Infosys shares jump 11% in three-day rally amid anti-AI play; should you buy, sell or hold?
NewsGoogle News·29 Jul · today
TCS, Infosys, Coforge jump up to 5%: Why are IT stocks rising for second straight day?
NewsGoogle News·29 Jul · yesterday
Infosys, TCS stocks jump 2-3%, Nifty IT up over 2% as easing US Fed rate-hike fears boost tech stocks
NewsGoogle News·27 Jul · 3d ago
Infosys Rallies 3% As Jefferies Adds Stock To Model Portfolio, Turns Neutral On IT
NewsGoogle News·27 Jul · 3d ago
9 other SEBI-registered advisors have active long-term BUY calls on this stock, with 5 issued in the last 14 days
Advisor consensus · same horizon·24 Jul · 6d ago
Infosys shares declines nearly 3 per cent after revised FY27 guidance
NewsGoogle News·24 Jul · 6d ago
1 other SEBI-registered advisor has an active long-term SELL call on this stock, issued in the last 14 days
Advisor consensus · same horizon·24 Jul · 6d ago
Infosys, Wipro ADRs crash up to 7% as IBM warning sends ripples across IT sector
NewsGoogle News·14 Jul · 2w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Infosys
- BUY — Rakesh Bansal6 Nov 2026 · ~2 weeks · target ₹1,225 · Active
- BUY — Rakesh Bansal5 Nov 2026 · Next day · target ₹1,212 · Expired
- BUY — Sumeet Bagadia, Choice Broking31 Oct 2026 · ~2 weeks · target ₹1,300 · Active
- BUY — Manas Jaiswal29 Oct 2026 · ~2 weeks · target ₹1,210 · SL hit
- BUY — Kunal Bothra27 Oct 2026 · Same day · target ₹1,200 · SL hit
More from Motilal Oswal
- BUY Zydus Lifesciences6 Nov 2026 · ~1 year · target ₹1,480 · Active
- BUY Neogen Chemicals6 Nov 2026 · ~1 year · target ₹2,765 · Active
- BUY BSE5 Nov 2026 · ~1 year · target ₹4,200 · Active
- BUY Apollo Hospitals Enterprise5 Nov 2026 · ~1 year · target ₹10,400 · Active
- BUY Bharat Electronics3 Nov 2026 · ~1 year · target ₹540 · Active

